Medicare Enrolled

Dr. Rhonda Gabr, M.D.

Neurology · Raleigh, NC
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
1540 SUNDAY DR, Raleigh, NC 27607
9197823456
In practice since 2006 (20 years)
NPI: 1609803949 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Gabr from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Gabr? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Gabr

Dr. Rhonda Gabr is a neurology specialist in Raleigh, NC, with 20 years of NPI registration. Based on federal Medicare data, Dr. Gabr performed 53,186 Medicare services across 637 unique beneficiaries.

Between the years covered by Open Payments, Dr. Gabr received a total of $2,098 from 34 pharmaceutical and/or device companies across 115 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Gabr is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 1% volume in NC $2,098 industry payments

Medicare Practice Summary

Medicare Utilization ↗
53,186
Medicare services
Top 1% in NC for neurology
637
Unique beneficiaries
$14
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~2,659 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Botox injection, per unit
An injection of onabotulinumtoxinA, a medication used to temporarily relax muscles or reduce gland activity. The dose is measured in units, with this code representing a single unit administered.
31,200 $5 $13
Injection, natalizumab, 1 mg 9,900 $19 $35
Ocrelizumab infusion (Ocrevus) for MS 6,300 $43 $110
MRI contrast dye injection (gadobutrol) 3,150 $0 $2
Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg 1,740 $39 $90
Bilateral facial and neck nerve muscle paralysis injection
Injection of a chemical agent to paralyze muscles in the face and neck on both sides.
157 $103 $560
Methylprednisolone injection, up to 125 mg
An injection of methylprednisolone sodium succinate, a corticosteroid medication, with a dosage of up to 125 mg.
99 $4 $15
Office visit, established patient (10-19 min)
An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition.
93 $40 $90
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
78 $59 $150
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
64 $129 $300
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
61 $86 $220
Intravenous chemotherapy infusion, 1 hour or less
Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete.
54 $91 $510
Intravenous infusion, 1 hour or less
Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less.
52 $47 $228
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
46 $115 $380
Awake and drowsy EEG
A test that records electrical activity in the brain while the patient is awake and drowsy.
38 $278 $720
Intravenous injection of additional new drug or substance
Administration of an additional new medication or substance directly into a vein.
38 $12 $100
Additional hour of intravenous infusion
This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis.
37 $16 $166
New patient office visit, complex (60-74 min) 28 $162 $430
MRI of brain with and without contrast
An MRI scan of the brain using contrast dye both before and after administration to provide detailed images of brain structures.
24 $162 $2,235
Additional hour of intravenous chemotherapy
This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period.
16 $20 $166
EEG, extended monitoring
A test that records electrical activity in the brain while the patient is both awake and asleep.
11 $331 $820
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
12.1% high complexity
87.2% medium
0.7% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$2,098
Total received (2018-2024)
Avg $300/year across 7 years
Top 39% in NC for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
34
Companies
115
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$1,872 (89.3%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$225 (10.7%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$665
2023
$546
2022
$281
2021
$14
2020
$57
2019
$272
2018
$263

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Alexion Pharmaceuticals, Inc.
$200
Novartis Pharmaceuticals Corporation
$84
ARGENX US, INC.
$54
ABBVIE INC.
$44
Neurelis, Inc.
$38
Aucta Pharmaceuticals, Inc.
$36
Neurocrine Biosciences, Inc.
$32
Lundbeck LLC
$31
TG Therapeutics, Inc.
$31
Eisai Inc.
$27
Biogen, Inc.
$20
PFIZER INC.
$20
UCB, Inc.
$19
Lilly USA, LLC
$15
Amneal Pharmaceuticals LLC
$14
Top 3 companies account for 50.9% of 2024 payments
All-time payments by company (2018-2024) ›
ABBVIE INC.
$486
GENZYME CORPORATION
$255
Alexion Pharmaceuticals, Inc.
$200
Novartis Pharmaceuticals Corporation
$159
Amgen Inc.
$91
Lundbeck LLC
$72
Lilly USA, LLC
$72
Allergan, Inc.
$60
ARGENX US, INC.
$54
CSL Behring
$51
Horizon Therapeutics plc
$40
Allergan Inc.
$38
Neurelis, Inc.
$38
EMD Serono, Inc.
$37
UCB, Inc.
$36
Aucta Pharmaceuticals, Inc.
$36
Merz North America, Inc.
$35
Neurocrine Biosciences, Inc.
$32
TG Therapeutics, Inc.
$31
Amneal Pharmaceuticals LLC
$29
Teva Pharmaceuticals USA, Inc.
$28
Eisai Inc.
$27
GE HealthCare
$25
TG THERAPEUTICS, INC.
$24
Biogen, Inc.
$20
PFIZER INC.
$20
Janssen Pharmaceuticals, Inc
$16
AbbVie Inc.
$14
Mallinckrodt Enterprises LLC
$13
Celgene Corporation
$13
Corium, LLC
$12
IMPEL PHARMACEUTICALS INC.
$12
Zyla Life Sciences
$11
Boston Scientific Corporation
$11
Top 3 companies account for 44.9% of all-time payments
Associated products mentioned in payments ›
ACTHAR · AJOVY · AMYVID · AUBAGIO · AUSTEDO · Adlarity · Aimovig · BOTOX · BOTOX - SPASTICITY · BRIUMVI · Briviact · EMGALITY · GENERAL DBS · GILENYA · Hizentra · INGREZZA · KESIMPTA · LEMTRADA · Leqembi · Mavenclad · Motpoly XR · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONGENTYS 50MG CAPSULES 30 · QULIPTA · RYTARY · Rebif · Rystiggo · TYSABRI · Trudhesa · UBRELVY · ULTOMIRIS · UPLIZNA · VALTOCO · VYEPTI · VYVGART HYTRULO · XEOMIN · ZEPOSIA · ZORVOLEX
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (89%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a neurology specialist in Raleigh?
Compare neurologists in the Raleigh area by procedure volume, costs, and industry payment transparency.
Browse neurologists nearby

Geographic Context

Neurologists within 10 mi
115
Per 100K population
10.0
County median income
$101,763
Nearest hospital
REX HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Gabr is a mixed practice specialist, with above-average Medicare volume (top 1% in NC), with low-engagement industry engagement, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Gabr experienced with botox injection, per unit?
Based on Medicare claims data, Dr. Gabr performed 31,200 botox injection, per unit services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Gabr receive payments from pharmaceutical companies?
Yes. Dr. Gabr received a total of $2,098 from 34 companies across 115 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Gabr's costs compare to other neurologists in Raleigh?
Dr. Gabr's average Medicare payment per service is $14. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Gabr) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →